Ann: MSB Clinical Program Update For MPC-150-IM In Heart Failure, page-46

Re Operational Update for Phase 3 Trial in NYHA Class II-III Advanced CHFPatients

On 28 Feb, with the half year result, MSB’s confirmed (PP presentation page 27)
Phase 3 trial targeted enrollment completion (2H CY18)

In the program update yesterday, MSB advised:
Phase 3 DREAM-HF Trial Targeting NYHA Class II/III Patients With Moderate-to-Advanced Chronic Heart Failure
Enrolment of this Phase 3 trial is expected to be completed by the end of 2018.

The 1st statement does not conflict with the 2nd but exludes any suggestion of an early read out in Q3